206 related articles for article (PubMed ID: 26909330)
1. Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson's disease.
Pikstra ARA; van der Hoorn A; Leenders KL; de Jong BM
Neuroimage Clin; 2016; 11():68-72. PubMed ID: 26909330
[TBL] [Abstract][Full Text] [Related]
2. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
[TBL] [Abstract][Full Text] [Related]
3. Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study.
Ghaemi M; Raethjen J; Hilker R; Rudolf J; Sobesky J; Deuschl G; Heiss WD
Mov Disord; 2002 Jul; 17(4):782-8. PubMed ID: 12210876
[TBL] [Abstract][Full Text] [Related]
4. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms.
Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Masuda K; Kato M
J Neurol Sci; 1996 Mar; 136(1-2):169-73. PubMed ID: 8815166
[TBL] [Abstract][Full Text] [Related]
5. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
Brooks DJ; Playford ED; Ibanez V; Sawle GV; Thompson PD; Findley LJ; Marsden CD
Neurology; 1992 Aug; 42(8):1554-60. PubMed ID: 1641153
[TBL] [Abstract][Full Text] [Related]
6. Detection of preclinical Parkinson's disease with PET.
Brooks DJ
Geriatrics; 1991 Aug; 46 Suppl 1():25-30. PubMed ID: 1909983
[TBL] [Abstract][Full Text] [Related]
7. Detection of preclinical Parkinson's disease with PET.
Brooks DJ
Neurology; 1991 May; 41(5 Suppl 2):24-7; discussion 28. PubMed ID: 1904139
[TBL] [Abstract][Full Text] [Related]
8. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
[TBL] [Abstract][Full Text] [Related]
9. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.
Rinne JO; Ruottinen H; Bergman J; Haaparanta M; Sonninen P; Solin O
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):737-41. PubMed ID: 10567489
[TBL] [Abstract][Full Text] [Related]
11.
Li W; Lao-Kaim NP; Roussakis AA; Martín-Bastida A; Valle-Guzman N; Paul G; Loane C; Widner H; Politis M; Foltynie T; Barker RA; Piccini P
Mov Disord; 2018 Jan; 33(1):117-127. PubMed ID: 29082547
[TBL] [Abstract][Full Text] [Related]
12. Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients.
Winogrodzka A; Wagenaar RC; Bergmans P; Vellinga A; Booij J; van Royen EA; van Emmerik RE; Stoof JC; Wolters EC
Mov Disord; 2001 Nov; 16(6):1033-40. PubMed ID: 11748734
[TBL] [Abstract][Full Text] [Related]
13. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
Brück A; Aalto S; Nurmi E; Vahlberg T; Bergman J; Rinne JO
Mov Disord; 2006 Jul; 21(7):958-63. PubMed ID: 16550545
[TBL] [Abstract][Full Text] [Related]
14. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
[TBL] [Abstract][Full Text] [Related]
15. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopa and glucose metabolism in PD patients with freezing of gait.
Bartels AL; de Jong BM; Giladi N; Schaafsma JD; Maguire RP; Veenma L; Pruim J; Balash Y; Youdim MB; Leenders KL
Mov Disord; 2006 Sep; 21(9):1326-32. PubMed ID: 16721756
[TBL] [Abstract][Full Text] [Related]
17. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.
Eshuis SA; Maguire RP; Leenders KL; Jonkman S; Jager PL
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235
[TBL] [Abstract][Full Text] [Related]
18. Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease.
Picco A; Morbelli S; Piccardo A; Arnaldi D; Girtler N; Brugnolo A; Bossert I; Marinelli L; Castaldi A; De Carli F; Campus C; Abbruzzese G; Nobili F
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1062-70. PubMed ID: 25820675
[TBL] [Abstract][Full Text] [Related]
19. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
[TBL] [Abstract][Full Text] [Related]
20. Relationship of irisin with disease severity and dopamine uptake in Parkinson's disease patients.
Shi X; Gu Q; Fu C; Ma J; Li D; Zheng J; Chen S; She Z; Qi X; Li X; Wu S; Wang L
Neuroimage Clin; 2024; 41():103555. PubMed ID: 38134742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
